Ulcerative colitis is a chronic inflammatory condition of the colon that can cause abdominal pain, tissue damage, and long-term digestive issues. In this study, researchers investigated whether a hemp extract rich in cannabidiol (CBD) and cannabigerol (CBG) could reduce symptoms of colitis using a well-established mouse model. The extract was administered both orally and by […]
Tag: CBG
CBG Demonstrates Anti-Inflammatory, Neuroprotective, and Antibacterial Activity (pub. Nov 2022)
Cannabigerol (CBG) is often called the “mother cannabinoid” because it serves as a precursor from which other major cannabinoids, including CBD and THC, are formed during the cannabis plant’s growth. In this 2022 scientific review, researchers examined the pharmacological properties of CBG and its synthetic derivatives, highlighting growing interest in the compound for its potential […]
Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Emerging Therapeutic Insights (pub. Feb 2026)
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and multiple sclerosis are closely linked to dysfunction of the blood–brain barrier (BBB)—a protective layer that regulates what enters and exits the brain. This review explores how cannabinoids interact with the BBB and the endocannabinoid system, which plays a key role in maintaining brain balance. Researchers highlight that in […]